Dr. Carrie Jose, in her latest Health and Wellness column, asks if regenerative therapy can be the future of healing for ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The following is a summary of “Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy,” published in the January 2025 issue of ...
As temperatures drop, many people experience dry, red, and itchy skin, a condition that often worsens in winter.
Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback